- The role of the immune system and the biomarker CD3+CD4+CD45RA-CD62L-in the pathophysiology of migraine2020 | Faculty of Medicine in Hradec Králové
- Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men2021 | Central Library of Charles University, First Faculty of Medicine
- Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport